Therefore, our results–namely, concurrent decreases of central BP, arterial reflection, cerebral pulsatilities and plasma NT-proBNP–can be a surrogate evidence that ARB can be a more favourable choice for stroke patients with hypertension. This evidence concerns the gene NPPB and Stroke.